Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory × Idarubicin × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 36 Myelodysplastic Syndromes 6 Leukemia, Biphenotypic, Acute 5 Leukemia 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myelomonocytic, Acute 3 Neoplasm, Residual 2 Myeloproliferative Disorders 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Congenital Abnormalities 2 Sarcoma, Myeloid 1 Neoplasms by Histologic Type 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphoma 1 Liver Neoplasms 1 Leukemia, Myeloid 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Hematologic Neoplasms 1 Down Syndrome 1 Carcinoma, Hepatocellular 1 Blast Crisis 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 2 Mycophenolic Acid 2 poly ICLC 1 fludarabine 1 Whole-Body Irradiation 1 Vorinostat 1 Tacrolimus 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 Melphalan 1 Injections 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Decitabine 1 Cyclosporine 1 Cyclophosphamide 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡